
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Technology Inc. is demonstrating significant financial strength, with an increased revenue guidance for FY 2025 of $6.5 million at the midpoint, reflecting anticipated growth in its lymphedema and AffloVest businesses. The company is also projecting robust gross margins of approximately 75% while managing operational expenditures with an anticipated increase of 11% year-over-year, indicating a focus on maintaining efficiency amidst growth investments. Additionally, a strategic expansion of the sales force and enhancements in productivity through new technology position Tactile Systems favorably for accelerated growth and improved market leadership moving into FY 2026.
Bears say
Tactile Systems Technology Inc. is facing a negative outlook primarily due to a downward revision in sales growth expectations for its lymphedema products, which has subsequently impacted overall revenue projections for the fourth quarter of 2025. Despite achieving higher-than-expected gross and operating margins, the company is contending with risks associated with slower commercial uptake, workforce optimization challenges, and competition in the airway clearance market. Furthermore, ongoing visibility concerns have been exacerbated by consecutive guidance reductions for the first and second quarters, raising doubts about the sustainability of revenue, which largely derives from lymphedema-related offerings.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares